Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical condition that can afflict people with a uterus, causing problems like chronic pelvic pain and fertility issues. Endometriosis affects nearly 200 million people worldwide. Getting […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Read More Details
Finally We wish PressBee provided you with enough information of ( University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis )
Also on site :
- With Property Seized and Federal Funding Uncertain, Montana Asbestos Clinic Fights for Its Life
- Which Stevie Nicks Song Matches You, Based on Zodiac Sign
- Met Office: Thunderstorm warning issued for parts of England in midst of 33C heatwave